OKO. A. Kupriushina

O. A. Kupriushina

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


O. A. Kupriushina has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Distinguishing Between Bacterial and Viral Community‐Acquired Pneumonia in Hospitalized Adults: The Importance of Clinical, Laboratory, and Imaging Findings

    by Daria Strelkova, Anastasia Yasneva, Olga Kupriushina, Sergey Avdeev, Anna Vlasenko, Lyudmila Fedina, Olga Ivanova, Ivan Zakharenkov, Inna Kaledina, Nataliia Ananicheva, et al.

    Background: Our study aims to compare patients with identified viral and bacterial pathogens and develop a predictive model for determining community‐acquired pneumonia (CAP) etiology. Methods: In this retrospective case–control study, hospitalized adults with confirmed bacterial or viral CAP were compared at a 1:3 ratio. Patients were matched by gender, hospitalization department, age, and Charlson comorbidity index. The etiology of CAP was established through blood and sputum culture, polymerase chain reaction of respiratory specimens, and urinary antigen tests. Both objective variables and subjective symptoms were assessed using multivariate conditional logistic regression. Results: Our study included 400 patients. Using the best‐developed model, we found that patients with bacterial CAP were more likely to exhibit unilateral infiltration on visualization (odds ratio [OR] 20.47; 95% confidence intervals [CI; 7.51–55.81], p < 0.001), experience chills (OR 20.69; 95% CI [6.08–70.38], p < 0.001), have a higher heart rate (OR 1.04; 95% CI [1.01–1.06], p = 0.001), and demonstrate an elevated neutrophils/lymphocytes ratio (OR 1.58; 95% CI [1.16–2.14], p = 0.003). They also showed a decreased level of consciousness (OR 3.16; [1.16–8.61], p = 0.024), and were more likely to receive vasopressors within the first 24 h of admission (OR 8.28; 95% CI [1.75–39.22], p = 0.008). Conversely, they were less likely to have general weakness (OR 0.20; 95% CI [0.09–0.47], p < 0.001) and tended to have lower total serum protein levels (OR 0.06; 95% CI [0.01–0.45], p = 0.006). This model showed sensitivity of 90%, specificity of 91%, and positive predictive value of 97%. Conclusion: The developed model offers a valuable tool for assessing the etiology of CAP upon admission.

  • Open Access

    Development of a model for the differential diagnosis of community-acquired bacterial pneumonia and viral lung injury in hospitalized adult patients

    by O. A. Kupriushina, D. A. Strelkova, A. S. Yasneva, S. A. Rachina, S. N. Avdeev, A. E. Vlasenko, L. V. Fedina, O. V. Ivanova, I. V. Kaledina, N. A. Ananicheva

    Relevance. During and after the COVID-19 pandemic, viruses have become a more common cause of pulmonary infections in adults; therefore, the distinction between viral lung injury and community-acquired bacterial pneumonia is of increasing importance. Aim. Development of a model for differentiating community-acquired bacterial pneumonia and viral lung injury, including COVID-19. Materials and methods. This retrospective case–control study included 300 adult patients with viral lung injury and 100 adult patients with community-acquired bacterial pneumonia. Clinical, laboratory, and instrumental data were analyzed, significant factors were selected by which the samples differed, and a model was developed using logistic regression to distinguish between community-acquired bacterial pneumonia and viral lung damage, including COVID-19. Results. The developed model included the following parameters: total protein level, neutrophil/lymphocyte index, heart rate, unilateral infiltration on CT or chest x-ray, vasopressor prescription in the first 24 h of hospitalization, altered level of consciousness, chills, and fatigue. The model had the following characteristics: AUC = 0.94 (0.92–0.96), AUC_PR = 0.84 (0.76 to 0.92), prediction accuracy — 90%, sensitivity — 76%, specificity — 95%, positive predictive value — 83 %. Conclusion. The use of this model can facilitate the differential diagnosis of community-acquired bacterial pneumonia and viral lung injury, including COVID-19, in adults in general wards and intensive care units.

  • Management of community-acquired pneumonia in adults with type 2 diabetes mellitus in a multidisciplinary hospital

    by R. E. Baysultanova, S. A. Rachina, I. M. Kotidis, O. A. Kupriushina, Saif Authman Khaleel Alhalaseh

    Community-acquired pneumonia (CAP) is a common acute infectious disease in adults. Diabetes mellitus (DM) increases the incidence of CAP and worsens the prognosis. In this regard, the assessment of the current practice of CAP management in patients with concomitant DM and its compliance with clinical guidelines is of great interest.Purpose. To study the current practice of CAP treatment in adult patients with concomitant type 2 DM in a multidisciplinary hospital and evaluate its compliance with the national clinical guidelines.Methods. A cross-sectional observational study was carried out in a pulmonology department of a republican clinical hospital. The study recruited adult patients with a confirmed diagnosis of CAP and previously diagnosed type 2 DM. For each case, demographic characteristics, the severity of CAP, the presence and nature of complications, systemic antibiotic therapy (ABT) and compliance with 16 quality indicators (QI) were recorded. The quality indicators described the adequacy of examination, treatment and secondary prevention of CAP in the presence of concomitant DM. QIs were chosen based on the national clinical guidelines for CAP and algorithms for specialized medical care for patients with DM.Results. Altogether, 48 patients with the average age of 63.9 ± 10.5 years were enrolled. 81% of patients had mild CAP. The severity criteria were assessed in 60% of the patients, prognosis – in 17% of the patients. X-ray examination, pulse oximetry and complete blood count were performed on time in 100% of the cases. A total of 19% of patients had a culture of respiratory specimens. A blood culture was performed in 11,11% of the cases of severe CAP (SCAP). Rapid urine tests for pneumococcal and legionella antigens have not been used. Glycemia was monitored daily in 27% of the patients. ABT was initiated on time in 100% of the patients.Conclusion. Low adherence to many QIs, insufficient control of glycemia and correction of sugar-lowering therapy in the treatment of hospitalized patients with CAP and concomitant type 2 DM were observed, which can worsen clinical outcomes.